2 Models Of Apple Watch Can Go On Sale Again, For Now
A federal court temporarily lifted a sales halt on two higher-end models of the Apple Watch ordered by the International Trade Commission due to a patent dispute.
Similar Posts
NFL Posts Highest Ratings Since 2015 Amid Taylor Swift-Fueled Surge in Interest
Updated Jan. 10, 2024 2:01 pm ET The National Football League lost several of its biggest stars to injuries during the just-completed regular season, including the quarterbacks of the New York Jets, Minnesota Vikings and Cincinnati Bengals. But a new NFL star emerged: superfan Taylor Swift. Swift’s attendance at several Kansas City Chiefs games to…
US budget: Spending deal reached as shutdown deadline looms
President Biden says the agreement “clears the way” for Congress to avoid a government shutdown.
NCAA and ESPN ink 8-year, $920 million media rights deal
An ESPN GameDay logo is displayed at the Capital One Orange Bowl game between the Georgia Bulldogs and the Florida State Seminoles at the Hard Rock Stadium in Miami Gardens, Florida, on Dec. 30, 2023. Peter Joneleit | Icon Sportswire | Getty Images The NCAA and ESPN have reached a new eight-year media rights deal…
Tesla on two wheels? India’s Ola Electric feels the strains of success | Reuters News Agency
AutomotiveBusiness & Finance 28 November 2023, 4:40 am 1 minute Reuters reported that Bhavish Aggarwal, India’s answer to Elon Musk, is racing to roll out millions of electric scooters and speed his nation to a cleaner future. Some of his mechanics can’t keep up, though. Aggarwal’s Ola Electric, which he likens to Tesla in the…
Tiger Woods ends Nike partnership after 27 years
Tiger Woods during the pro-am as a preview for the Hero World Challenge at Albany Golf Course in Nassau on Nov. 29, 2023. David Cannon | Getty Images Tiger Woods’ 27-year partnership with Nike has come to an end. The superstar golfer announced the news in a statement Monday on social media platform X. “Phil…
Merck to Buy Harpoon Therapeutics for $680 Million
Merck & Co.has struck a deal to buy clinical-stage immunotherapy company Harpoon Therapeutics for about $680 million. Merck on Monday said it will pay $23 a share in cash for Harpoon, more than double Friday’s closing price of $10.55 for the South San Francisco, Calif., company. Copyright ©2024 Dow Jones & Company, Inc. All Rights…
